piperaquine has been researched along with Co-infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuesap, J; Rungsihirunrat, K; Suphakhonchuwong, N | 1 |
| Bass, JK; Bigira, V; Boivin, MJ; Dorsey, G; Familiar-Lopez, I; Kamya, M; Kapisi, J; Muhindo, M; Nakasujja, N; Opoka, RO; Ruiseñor-Escudero, H; Sikorskii, A | 1 |
1 trial(s) available for piperaquine and Co-infection
| Article | Year |
|---|---|
Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children.
Topics: Age Factors; Anemia; Antimalarials; Artemisinins; Child, Preschool; Cognition; Cognition Disorders; Coinfection; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Quinolines; Risk Factors; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2016 |
1 other study(ies) available for piperaquine and Co-infection
| Article | Year |
|---|---|
Surveillance of drug resistance molecular markers in Plasmodium vivax before and after introduction of dihydroartemisinin and piperaquine in Thailand: 2009-2019.
Topics: Antimalarials; Biomarkers; Coinfection; Drug Resistance; Humans; Malaria, Vivax; Mutation; Plasmodium vivax; Protozoan Proteins; Thailand | 2023 |